(14) identified that serum inflammatory cytokine levels correspond with vemurafenib treatment, and that RAF inhibition leads to a reduction in the expression of cytokines such as IL1B and CXCL8, which are associated with LCH. The gene discussed is IL1B; the disease is Langerhans cell histiocytosis.